Associated Papers
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.
Lucas CG et al.
Neuro-oncology, 2025
39560080 (PubMed )
Supplement: noae214_suppl_supplementary_tables.xlsx › Table_S6
Genomic Profiling in Glioma Patients to Explore Clinically Relevant Markers.
Varachev V et al.
International Journal of Molecular Sciences, 2024
39684714 (PubMed )
Supplement: ijms-25-13004-s001.zip › Table_S1._Examples_of_somatic_genetic_alterations_in_glioma_samples.xlsx › ____1
Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission Risk.
Chen JL et al.
Annual Review of Genomics and Human Genetics, 2022
36044908 (PubMed )
Supplement: gg23-giannikou_suptable1.xlsx › NF1
Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression.
Kang E et al.
Orphanet Journal of Rare Diseases, 2022
Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use.
Shi Z et al.
Plos One, 2022
A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer.
Kaur P et al.
International Journal of Molecular Sciences, 2020
MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers.
Wyce A et al.
Oncogenesis, 2018
29674704 (PubMed )
Supplement: 41389_2018_43_MOESM5_ESM.pdf
A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.
Way GP et al.
Bmc Genomics, 2017
28166733 (PubMed )
Supplement: 12864_2017_3519_MOESM1_ESM.xlsx › NF1_Supplementary_Table_S1
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.
Hirshfield KM et al.
The Oncologist, 2016
27566247 (PubMed )
Supplement: supp_the2016-0049_Supplemental_Tables.pdf
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
Churi CR et al.
Plos One, 2014
25536104 (PubMed )
Supplement: pone.0115383.s001.xlsx › Sheet_1
Select a paper to view details